| __timestamp | Arrowhead Pharmaceuticals, Inc. | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 621276000 |
| Thursday, January 1, 2015 | 382000 | 737887000 |
| Friday, January 1, 2016 | 158333 | 907234000 |
| Sunday, January 1, 2017 | 31407709 | 1071860000 |
| Monday, January 1, 2018 | 16142321 | 1175948000 |
| Tuesday, January 1, 2019 | 168795577 | 1344582000 |
| Wednesday, January 1, 2020 | 87992066 | 1336183000 |
| Friday, January 1, 2021 | 138287000 | 1375760000 |
| Saturday, January 1, 2022 | 232810000 | 1612370000 |
| Sunday, January 1, 2023 | 240735000 | 1842161000 |
| Monday, January 1, 2024 | 3551000 | 2273680000 |
Infusing magic into the data realm
In the ever-evolving biotech industry, understanding financial trends is crucial. This analysis delves into the gross profit trajectories of BioMarin Pharmaceutical Inc. and Arrowhead Pharmaceuticals, Inc. from 2014 to 2023. BioMarin, a leader in rare disease therapies, consistently outperformed Arrowhead, with gross profits peaking at approximately $1.84 billion in 2023, marking a 196% increase from 2014. In contrast, Arrowhead, known for its RNA interference therapies, showed a remarkable growth of over 137,000% in the same period, reaching $240 million in 2023. However, 2024 data for BioMarin is missing, indicating potential reporting delays or strategic shifts. This decade-long analysis highlights the dynamic nature of biotech financials, emphasizing the importance of innovation and market adaptation. Stay tuned for more insights into the financial health of leading biotech firms.
Gross Profit Trends Compared: Johnson & Johnson vs BioMarin Pharmaceutical Inc.
AstraZeneca PLC and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing GSK plc and BioMarin Pharmaceutical Inc.
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Biogen Inc. vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Incyte Corporation and Arrowhead Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Vericel Corporation
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Veracyte, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and MiMedx Group, Inc.